Cargando…
Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase
Pulmonary tuberculosis, caused by Mycobacterium tuberculosis, is one of the most persistent diseases leading to death in humans. As one of the key targets during the latent/dormant stage of M. tuberculosis, isocitrate lyase (ICL) has been a subject of interest for new tuberculosis therapeutics. In t...
Autores principales: | Ibeji, Collins U., Salleh, Nor Amirah Mohd, Sum, Jia Siang, Ch’ng, Angela Chiew Wen, Lim, Theam Soon, Choong, Yee Siew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609661/ https://www.ncbi.nlm.nih.gov/pubmed/33144641 http://dx.doi.org/10.1038/s41598-020-75799-8 |
Ejemplares similares
-
Potential Inhibitors for Isocitrate Lyase of Mycobacterium tuberculosis and Non-M. tuberculosis: A Summary
por: Lee, Yie-Vern, et al.
Publicado: (2015) -
Subtractive panning for the isolation of monoclonal PEPITEM peptide antibody by phage display
por: Alassiri, Mohammed, et al.
Publicado: (2023) -
Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2
por: Bhusal, Ram Prasad, et al.
Publicado: (2019) -
Modulation of Central Carbon Metabolism by Acetylation of Isocitrate Lyase in Mycobacterium tuberculosis
por: Bi, Jing, et al.
Publicado: (2017) -
Discovery of a Novel Inhibitor Structure of Mycobacterium tuberculosis Isocitrate Lyase
por: Duan, Changyuan, et al.
Publicado: (2022)